back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-24 15:07 Tx date 2023-05-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,461 vol |
11,961 | |
| Filed 2023-05-24 15:05 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
| Filed 2022-05-23 11:14 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
130,959 | |
| Filed 2022-05-23 11:07 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
| Filed 2022-05-23 11:06 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-04 17:32 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,765.86
-634 vol $23.29 each |
3,500 | |
| Filed 2022-01-04 17:32 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-888,884.28
-39,366 vol $22.58 each |
4,134 | |
| Filed 2022-01-04 17:29 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$203,200
+40,000 vol $5.08 each |
43,500 | |
| Filed 2022-01-04 17:27 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-256,000
-40,000 vol $6.40 each |
116,347 | |
| Filed 2021-06-17 17:03 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
156,347 | |
| Filed 2020-06-16 11:55 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
125,000 | |
| Filed 2020-06-03 20:22 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
| Filed 2020-06-03 20:22 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
125,000 | |
| Filed 2019-10-15 16:30 Tx date 2019-10-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,510
+2,000 vol $4.75 each |
3,500 | |
| Filed 2019-10-15 16:29 Tx date 2019-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,803
+1,500 vol $3.87 each |
1,500 | |
| Filed 2019-10-15 16:28 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-05 12:46 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
| Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
| Filed 2018-02-14 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-14 Tx date 2018-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$320,000
+50,000 vol $6.40 each |
50,000 |